templeton

Peter Wilmshurst

Allergan (NYSE: AGN) is a specialty pharmaceutical company operating in the research, development and manufacture of pharmaceutical products. The company offers a portfolio of products that provide treatment for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, medical aesthetics, dermatology, plastic surgery, liver disease, inflammation, metabolic syndromes,... Show More

Peter Wilmshurst

The US market has become more complex. Earnings have been strong during 2017 but multiples are highly elevated, meaning there are increasingly fewer opportunities. One of the biggest risks for markets would have to be US equities. It’s more than 50% of the MSCI World Index, and where many people... Show More

Peter Wilmshurst

We know Europe has been through a touch economic cycle over the last few years since the GFC. That's somewhat on the mend now. Once the European earnings come through, the markets will start to appreciate that and reward those stocks - both with a re-rating as well as seeing... Show More

Livewire News

Advice from the world's top 20 market minds. Forbes have rounded up the 20 finest market minds -- dead or alive -- and distilled their timeless wisdom into one slideshow. Features: Templeton, Buffett, Rothschild, Lynch, Tepper, Ichan, Grantham & Soros. Read their insights here: http://www.forbes.com/pictures/fkmm45jihh/advice-from-the-worlds-top-market-minds/ Show More